Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (101-110 of 326) with videos related to

Pageof 33
Sort By:
F1000Research|May 20, 2024
Hepatocellular carcinoma: Advances in systemic therapiesTrevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
Journal of Gastroenterology and Hepatology|October 5, 2023
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patientsKarin Kan, Danny Ka-Ho Wong, Rex Wan-Hin Hui, et al.
Carcinogenesis|March 30, 2022
Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell deathFung-Yu Huang, Danny Ka-Ho Wong, Lung-Yi Mak, et al.
The American Journal of Gastroenterology|August 10, 2011
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatmentJames Fung, Ching-Lung Lai, John Young, et al.
Antiviral Therapy|August 26, 2009
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapyMan-Fung Yuen, James Fung, Wai-Kay Seto, et al.
Journal of Medical Virology|September 15, 2011
Stability of hepatitis B surface antigen over time: implications for studies using stored seraJames Fung, Ching-Lung Lai, John Young, et al.
Clinical and Molecular Hepatology|October 20, 2022
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisKa Shing Cheung, Chiu Hang Mok, Xianhua Mao, et al.
JHEP Reports : Innovation in Hepatology|May 29, 2020
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closedChing-Lung Lai, Danny Ka-Ho Wong, Gerald Tsz-Yau Wong, et al.
Cell Death Discovery|May 1, 2021
Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinomaFung-Yu Huang, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
Annals of Medicine|February 10, 2024
Development and validation of HBV surveillance models using big data and machine learningWeinan Dong, Cecilia Clara Da Roza, Dandan Cheng, et al.
Pageof 33

Showing results (101-110 of 326) with videos related to

Sort By:
Pageof 33
F1000Research|May 20, 2024
Hepatocellular carcinoma: Advances in systemic therapiesTrevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
Journal of Gastroenterology and Hepatology|October 5, 2023
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patientsKarin Kan, Danny Ka-Ho Wong, Rex Wan-Hin Hui, et al.
Carcinogenesis|March 30, 2022
Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell deathFung-Yu Huang, Danny Ka-Ho Wong, Lung-Yi Mak, et al.
The American Journal of Gastroenterology|August 10, 2011
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatmentJames Fung, Ching-Lung Lai, John Young, et al.
Antiviral Therapy|August 26, 2009
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapyMan-Fung Yuen, James Fung, Wai-Kay Seto, et al.
Journal of Medical Virology|September 15, 2011
Stability of hepatitis B surface antigen over time: implications for studies using stored seraJames Fung, Ching-Lung Lai, John Young, et al.
Clinical and Molecular Hepatology|October 20, 2022
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisKa Shing Cheung, Chiu Hang Mok, Xianhua Mao, et al.
JHEP Reports : Innovation in Hepatology|May 29, 2020
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closedChing-Lung Lai, Danny Ka-Ho Wong, Gerald Tsz-Yau Wong, et al.
Cell Death Discovery|May 1, 2021
Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinomaFung-Yu Huang, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
Annals of Medicine|February 10, 2024
Development and validation of HBV surveillance models using big data and machine learningWeinan Dong, Cecilia Clara Da Roza, Dandan Cheng, et al.
Pageof 33